1. Home
  2. WBX vs FATE Comparison

WBX vs FATE Comparison

Compare WBX & FATE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WBX
  • FATE
  • Stock Information
  • Founded
  • WBX 2015
  • FATE 2007
  • Country
  • WBX Spain
  • FATE United States
  • Employees
  • WBX N/A
  • FATE N/A
  • Industry
  • WBX Industrial Specialties
  • FATE Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • WBX Consumer Discretionary
  • FATE Health Care
  • Exchange
  • WBX Nasdaq
  • FATE Nasdaq
  • Market Cap
  • WBX 92.2M
  • FATE 108.2M
  • IPO Year
  • WBX N/A
  • FATE 2013
  • Fundamental
  • Price
  • WBX $0.30
  • FATE $0.70
  • Analyst Decision
  • WBX Buy
  • FATE Hold
  • Analyst Count
  • WBX 3
  • FATE 8
  • Target Price
  • WBX $0.83
  • FATE $5.43
  • AVG Volume (30 Days)
  • WBX 374.0K
  • FATE 1.7M
  • Earning Date
  • WBX 05-08-2025
  • FATE 05-08-2025
  • Dividend Yield
  • WBX N/A
  • FATE N/A
  • EPS Growth
  • WBX N/A
  • FATE N/A
  • EPS
  • WBX N/A
  • FATE N/A
  • Revenue
  • WBX $169,730,821.00
  • FATE $13,631,000.00
  • Revenue This Year
  • WBX $0.51
  • FATE N/A
  • Revenue Next Year
  • WBX $38.01
  • FATE N/A
  • P/E Ratio
  • WBX N/A
  • FATE N/A
  • Revenue Growth
  • WBX 14.03
  • FATE N/A
  • 52 Week Low
  • WBX $0.29
  • FATE $0.68
  • 52 Week High
  • WBX $1.73
  • FATE $7.35
  • Technical
  • Relative Strength Index (RSI)
  • WBX 31.10
  • FATE 28.03
  • Support Level
  • WBX $0.29
  • FATE $0.83
  • Resistance Level
  • WBX $0.36
  • FATE $0.82
  • Average True Range (ATR)
  • WBX 0.03
  • FATE 0.06
  • MACD
  • WBX 0.00
  • FATE -0.01
  • Stochastic Oscillator
  • WBX 0.40
  • FATE 0.00

About WBX Wallbox N.V.

Wallbox NV is a smart electric vehicle charging and energy management company. It creates smart charging system combining technology design that manages the communication between user, vehicle, grid, building, and charger. The company is engaged in designing, manufacturing, and distributing faster, simpler EV charging solutions for residential, business, and public use. Its smart charging product portfolio includes Level 2 alternating current chargers for home and business applications and direct current fast chargers for public applications. The company has three reportable operating segments; Europe, Middle East and Asia (EMEA) which is also its key revenue generating segment, North America, and Asia‑Pacific.

About FATE Fate Therapeutics Inc.

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.

Share on Social Networks: